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ABSTRACT Collagen receptor integrins recycle between the plasma membrane and endo-
somes and facilitate formation and turnover of focal adhesions. In contrast, clustering of α2β1 
integrin with antibodies or the human pathogen echovirus 1 (EV1) causes redistribution of α2 
integrin to perinuclear multivesicular bodies, α2-MVBs. We show here that the internalized 
clustered α2 integrin remains in α2-MVBs and is not recycled back to the plasma membrane. 
Instead, receptor clustering and internalization lead to an accelerated down-regulation of 
α2β1 integrin compared to the slow turnover of unclustered α2 integrin. EV1 infection or 
integrin degradation is not associated with proteasomal or autophagosomal processes and 
shows no significant association with lysosomal pathway. In contrast, degradation is depen-
dent on calpains, such that it is blocked by calpain inhibitors. We show that active calpain is 
present in α2-MVBs, internalized clustered α2β1 integrin coprecipitates with calpain-1, and 
calpain enzymes can degrade α2β1 integrin. In conclusion, we identified a novel virus- and 
clustering-specific pathway that diverts α2β1 integrin from its normal endo/exocytic traffic to 
a nonrecycling, calpain-dependent degradative endosomal route.
INTRODUCTION
Integrins mediate cell attachment to extracellular matrix (ECM) by 
direct binding to for example, collagen and fibronectin. Binding to 
ECM causes integrin-dependent formation of focal contacts that are 
constantly broken and renewed in different locations to facilitate mi-
gration and attachment. α2β1 integrin is a collagen-binding integrin 
associated with important physiological and pathological processes, 
such as cell migration, inflammation, and cancer. Integrins are con-
stantly endocytosed and recycled back to the plasma membrane. 
β1 integrin internalization and recycling involve a large number of 
regulators, including protein kinase Cα (PKCα) and ε (Ng et al., 
1999; Ivaska et al., 2005), Arf6 and Rabs 5, 21, and 11, and Rab-
coupling protein (Powelka et al., 2004; Pellinen et al., 2006; Caswell 
et al., 2009).
Binding of another ligand, namely the human echovirus 1 (EV1), 
to α2β1 integrin does not trigger focal contact formation. The virus–
receptor complex is internalized from lipid rafts to the perinuclear 
cytoplasm, where it accumulates in α2 integrin–enriched multive-
sicular bodies (α2-MVBs; Marjomäki et al., 2002; Upla et al., 2004; 
Karjalainen et al., 2008). According to recent data, EV1 prefers bind-
ing to the inactive conformation of α2 integrin on the plasma mem-
brane, whereas the active conformation binds to collagen ligand 
(Jokinen et al., 2010). EV1 binding induces clustering of α2β1 integ-
rin. This can be efficiently mimicked by a sequential treatment with 
primary anti-α2 and secondary antibodies (Upla et al., 2004). The 
internalization of the clustered integrins requires Rac1, Pak1, and 
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clustered α2 integrin in human osteosarcoma SAOS-α2β1 cells for 
6 h. Unclustered α2 integrin (labeled with fluorescent monovalent 
Fab fragment) was found mainly on the plasma membrane and to 
some extent in cytosolic vesicles (Figure 1A). In contrast, secondary 
antibody or EV1 binding induced the clustering of monovalent 
Fab–α2 integrin conjugate and triggered EV1–α2β1 integrin coint-
ernalization into cytosolic vesicles (Figure 1, B and C, and Supple-
mental Figure S1A). Of interest, antibody clustering resulted in 
>60% and EV1 clustering in an even more prominent reduction of 
the Fab–α2 integrin fluorescence signal between 2 and 6 h. In con-
trast, no obvious down-regulation of α2β1 signal was observed in 
the unclustered cells during this time (Figure 1A). The clustering-in-
duced integrin turnover was much accelerated compared with the 
long half-life of unclustered integrin, as detected with pulse-chase 
labeling experiments (Figure 1D). To verify that the loss of fluores-
cence signal was due to degradation of α2 integrin and not only the 
labeled Fab fragment, two approaches were taken. First, we ana-
lyzed integrin down-regulation by comparing signal intensities of 
endocytosed anti-α2 antibody (MCΑ2025) with postfixation staining 
intensities obtained with biotinylated anti–α2 integrin antibody 
(A211E10) that recognizes another domain of the integrin following 
internalization for 2 and 24 h. The confocal images showed bright 
labeling of α2-MVBs after 2 h with both antibodies, but the labeling 
was considerably reduced after 24 h (Figure 1E). This suggests that 
the loss in the fluorescence signal was not due to degradation of the 
endocytosed antibody but indeed integrin down-regulation. Sec-
ond, we analyzed the turnover rate of α2β1 integrin using surface 
biotinylation. After surface biotinylation we induced integrin cluster-
ing, and after internalization we immunoprecipitated the clustered 
integrin from lysed cells using the secondary clustering antibody 
(Figure 1F). The results show that the amount of both α2 and β1 
subunits of the clustered heterodimeric integrin decreased signifi-
cantly during 24 h. In contrast, in the absence of integrin clustering 
no significant changes were observed in biotinylated receptor levels 
after 24 h. This result is in line with the metabolic labeling shown in 
Figure 1D and suggests that, without clustering, the turnover rate of 
α2β1 integrin is very slow. These results, taken together, demon-
strate that α2 integrin is down-regulated after clustering with a much 
more rapid turnover rate than during normal recycling.
The clustered α2 integrin is not recycled back to the 
plasma membrane
Because the integrin signal in α2-MVBs decreased with time, we 
wanted to investigate whether integrin recycling to the plasma 
membrane was contributing to this. We found that no recycling of 
the clustered and endocytosed α2 integrin was detected using 
three independent approaches.
First, we performed a recycling assay based on antibodies that 
quench Alexa 488 fluorescence on the plasma membrane, as de-
scribed before (van Kerkhof et al., 2005; Yuseff et al., 2007). After 
clustering and internalization of α2 integrin with Alexa 488–labeled 
antibody for 1 h, the plasma membrane fluorescence was quenched 
with an anti–Alexa 488 antibody (Figure 2A). Quenching was re-
peated with 1-h intervals during the subsequent 2–5 h of incubation 
before fixation. Anti–Alexa 488 antibody treatment after 1 h did not 
markedly reduce the fluorescence, suggesting that the integrin was 
already efficiently internalized to the cytoplasm. Furthermore, there 
was no significant difference between the quenched and un-
quenched samples between 2 and 5 h, indicating that the clustered 
α2 integrin did not recycle to the plasma membrane. As a compari-
son, we performed a similar experiment with unclustered α2 integ-
rin. The anti–Alexa 488 treatment after 1 h of internalization showed 
PKCα activation, and the macropinocytic uptake is also facilitated 
by CtBP/Bars (Karjalainen et al., 2008; Liberali et al., 2008). α2β1 
integrin and EV1 remain in the α2-MVBs until the structure releases 
the virus genome into the cytoplasm, which then promotes the 
startup of viral replication (Upla et al., 2008).
In addition to EV1, multivesicular endosomes are used by sev-
eral other viruses, such as human rhinovirus 2 minor group, influ-
enza A, and vesicular stomatitis virus, for their infectious entry into 
cells (Khor et al., 2003; Le Blanc et al., 2005; Fuchs and Blaas, 2010). 
The cell surface receptors for viruses are often commonly endocy-
tosed molecules such as integrins or growth factor or chemokine 
receptors (Mercer et al., 2010). As with their physiological ligands, 
virus-bound receptors may undergo recycling or down-regulation. 
According to the classic model for receptor down-regulation, endo-
cytosed receptors are sorted into intraluminal vesicles of multive-
sicular bodies and further guided to lysosomes for degradation. 
Degradation occurs in lysosomes by acidic hydrolases, and the 
degradation may be inhibited by several inhibitors acting on lyso-
somal hydrolases (Pillay et al., 2002; van der Goot and Gruenberg, 
2006). In addition to lysosomes, there are also other cellular ma-
chineries that are involved in protein degradation. Polyubiquit-
inated intracellular proteins can be down-regulated in proteasomes, 
and entire organelles can be sorted to lysosomes for degradation 
through macroautophagy or smaller cytosolic components through 
microautophagy (Ciechanover, 2005).
Calpains are calcium-dependent cytosolic cysteine proteases. 
Two major isozymes of calpains are calpain-1 and calpain-2, also 
called μ- and m-calpains, respectively, based on their requirement of 
calcium for protease activity. In addition to these most common and 
best-studied forms of calpains, there are also other tissue-specific 
calpains (Suzuki and Ohno, 1990; Suzuki and Sorimachi, 1998; Goll 
et al., 2003). More than 100 substrates for calpains have been found, 
including transcription factors, transmembrane receptors, and cy-
toskeletal proteins, as well as focal adhesion and signaling mole-
cules (Goll et al., 2003; Franco and Huttenlocher, 2005). In addition, 
β integrin cytoplasmic domains, including β1 integrin, have been 
shown to be subjected to calpain cleavage (Pfaff et al., 1999). No 
specific sequences have been found to act as cleavage sites for cal-
pains, but they instead seem to recognize more-global structural 
elements (Tompa et al., 2004). Calpain molecule consists of an 
80-kDa, large catalytic subunit and a 30-kDa, small regulatory sub-
unit. Autolysis of the 80-kDa catalytic domain to 78- and 76-kDa 
forms is usually associated with calpain activation, probably by low-
ering the requirement for calcium (Suzuki and Sorimachi, 1998; Goll 
et al., 2003; Franco and Huttenlocher, 2005; Hanna et al., 2008). 
Previously it was shown that in addition to lysosomal degradation, 
calpain and proteasomal degradation also may contribute to the β1 
integrin turnover in cells (Moro et al., 2004).
Here we show that clustering of α2β1 integrin, which mimics EV1 
infection, results in efficient internalization and accumulation of the 
receptor in α2-MVBs. In contrast to the endosomal recycling de-
scribed for the normal β1 integrin life cycle, clustered α2β1 integrin 
does not recycle back to the plasma membrane, but instead under-
goes down-regulation promoted by calpains in nonlysosomal α2-
MVBs.
RESULTS
α2-MVBs are degradative structures
EV1 infection and clustering of α2 integrin with antibodies result in 
accumulation of the receptor to α2-MVBs (Karjalainen et al., 2008). 
To investigate integrin traffic along this pathway in more detail, we 
followed the distribution of unclustered, EV1-bound or antibody-
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what higher values for the unquenched con-
trol intensities, suggesting a slow recycling 
of the control integrin back to the plasma 
membrane.
Second, we performed a fluorescence 
photobleaching experiment in order to see 
whether the clustered and internalized fluo-
rescent integrin was recycling back to the 
plasma membrane. Before bleaching and 
internalization, the clustered α2 integrin la-
beling showed a typical diffuse appearance 
of small clusters throughout the cell surface 
(Figure 2C, Ctrl). After a 2.5-h internalization 
period virus-clustered integrin showed large 
vesicle accumulations in the cytoplasm be-
side the nucleus. Fluorescence was bleached 
from the cell outside of the perinuclear ves-
icles, and the appearance of fluorescence to 
cell edges was monitored using 1-h inter-
vals. These data show that the perinuclear 
α2-MVBs remained mainly static and that 
the cytoplasmic and plasma membrane flu-
orescence signal did not increase after 
bleaching, suggesting that recycling did not 
occur during the total follow-up period of 
6.5 h (Figure 2C).
Third, we labeled the α2 integrins for 
electron microscopy using antibody-conju-
gated protein A–gold (PA-gold) as described 
before (Upla et al., 2004) and measured the 
areas of the α2 integrin–positive structures 
and their distances from the nucleus (Figure 
2D and Supplemental Figure S1B). In addi-
tion, we determined the number of PA-gold 
patches on the cell membrane. We found 
that the distance of α2 integrin structures 
from the nucleus did not change between 
the 2- and 24-h time points, suggesting that 
structures were located in the same perinu-
clear area in the cell at both time points. In 
addition, the quantified area of the vesicles 
remained similar after 2 and 24 h. Further-
more, the number of PA-gold positive 
patches on the plasma membrane did not 
increase after 2 h, further suggesting that 
there was no recycling of integrin between 
2 and 24 h.
Taken together, the data from these 
three independent approaches unambigu-
ously demonstrate that integrin is not recy-
cled after clustering and further suggest that 
the intensity reduction observed in the α2-
MVBs may be due to integrin degradation 
in the vesicles.
α2-MVBs do not overlap with 
lysosomal markers
The down-regulation of numerous ligands 
and receptors targeted to multivesicular bodies is suggested to take 
place in lysosomes by acid hydrolases in low pH. Of interest, recent 
data indicate that α5 integrin can be guided to lysosomal degrada-
tion together with fibronectin in migrating fibroblasts (Lobert et al., 
that 70% of the α2 integrin pool was sensitive to the treatment, sug-
gesting that the majority of α2 integrin was on the plasma mem-
brane (Figure 2B). Comparison of the fluorescence intensities with 
or without the subsequent anti–Alexa 488 treatments showed some-
FIGURE 1: Clustered α2 integrin is degraded in α2-MVBs. (A) In SAOS-α2β1 cells, α2 integrin 
was labeled on the cell surface with anti–α2 integrin antibody (MCA2025) and unclustering goat 
anti–mouse Fab DyLight 549 fragment. The α2 integrin–Fab conjugate was then internalized for 
0, 2, and 6 h and imaged with similar confocal settings. Confocal sections through the cells were 
projected together. Bars, 10 μm. (B) In addition to α2 integrin–Fab label (described in A), EV1 
was bound to cells on ice before internalization. Cells were imaged as described. Bars, 10 μm. 
(C) α2 integrin was clustered with anti–α2 integrin MCA2025 and clustering goat anti–mouse 
Alexa 555 antibodies (+ab clust.). Intensity of fluorescence signal (A–C) was measured from 
confocal three-dimensional sections of single cells. Altogether 30 cells from three independent 
experiments were analyzed. Mean values ± SE are shown. (D) Normal turnover rate of α2 
integrin was determined from metabolically labeled and immunoprecipitated samples. 
Quantification of gel bands was done with Adobe Photoshop, and the results are shown as 
averages of three independent experiments (±SE). (E) To evaluate the degradation of α2 integrin 
in α2-MVBs in more detail, integrin was labeled on the cell surface and after fixation again with 
another antibody: α2 integrin was first clustered with anti–α2 integrin MCA2025 antibody, 
followed by clustering with goat anti–mouse Alexa 555 antibody. After internalization for 2 and 
24 h, cells were labeled with another antixα2 integrin antibody, biotinylated A211E10, and 
streptavidin–Alexa 488 (green). Fluorescence intensity was measured from confocal z-stacks of 
30 cells from three independent experiments (±SE). Bars, 10 μm. (F) Degradation of α2 integrin 
was followed also after surface biotinylation of all proteins and by immunoprecipitating the 
integrin clusters (clustered) or unclustered α2 integrin (unclustered) via the clustering antibody 
or integrin antibody, respectively. Control cells were treated with the clustering secondary 
antibody without the primary antibody.
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15 min postinfection (p.i.; Figure 3), and only 23% of the structures 
show intraluminal vesicles (ILVs), the hallmark of MVBs (Karjalainen 
et al. 2008). However, already at 30 min p.i., the number of larger 
vesicular structures with ILVs clearly increased (∼45%). After 2 and 
3 h, already 72 and 90% of the structures are matured multivesicular 
bodies, respectively. EM observations after 6 h verify that the struc-
tures no longer show any signs of tubulovesicular “early elemental” 
2010). Because our recent data suggested that α2-MVBs are not 
particularly acidic and lack many tested markers of the clathrin-de-
pendent pathway (Karjalainen et al., 2011), we wanted to character-
ize these novel MVBs more carefully both by electron microscopy 
(EM) and confocal microscopy.
EM of internalized clustered α2β1 integrin showed rather large 
tubulovesicular structures during early time points, for example, 
FIGURE 2: Clustered α2 integrin is not recycled back to the plasma membrane. Recycling of (A) clustered and 
(B) unclustered α2 integrin was analyzed in SAOS-α2β1 cells by measuring the fluorescence intensity of surface-labeled 
integrin (Alexa 488) using repetitive treatments with the quenching anti–Alexa 488 antibodies. First, integrin was 
allowed to internalize for 1 h at 37°C and then treated with anti–Alexa 488 on ice for 30 min. Anti–Alexa 488 antibody 
treatment was thereafter repeated after 1-h intervals during subsequent incubations at 37°C for 4 h. Fluorescence 
intensity was measured from confocal z-stacks of images containing several cells. Altogether more than 50 cells from 
three independent experiments were analyzed. Results are shown as normalized mean values (±SE). (C) Recycling of α2 
integrin from α2-MVBs back to plasma membrane was followed in living cells. Fab-DyLight 488–labeled α2 integrin was 
clustered with EV1 and internalized for 2.5 h. The edges of the cells were bleached, and trafficking of α2 integrin was 
observed at 1-h intervals. Average intensity of the bleached areas was quantified from three-dimensional sections. Bars, 
10 μm. (D) The localization and size of α2 integrin–positive structures were determined from electron microscopy 
samples. First, anti–α2 integrin antibody was bound on cells on ice, followed by the clustering secondary antibody 
(rabbit anti-mouse) and protein A gold (10 nm). The gold clusters were allowed to internalize for 2 and 24 h. The size 
and location of gold particle positive structures were measured from 15 cells from two separate experiments (±SE) with 
iTEM software (Olympus). Altogether 75 and 108 vesicles were measured at 2 or 24 h, respectively.
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α2-MVBs are not highly acidic
Because low endosomal pH is known to be critical for cargo degra-
dation, at least in lysosomes, we were interested in measuring the 
intraendosomal pH in α2-MVBs at late time points. In line with the 
negligible labeling with lysotracker in our previous studies (Pietiäinen 
et al. 2004; Karjalainen et al., 2011), these endosomes showed 
close-to-neutral pH values during the first 3 h of internalization 
(Karjalainen et al., 2011). We used a similar protocol here for later 
time points relevant for degradation and included two different an-
tibody conjugates in the integrin clustering protocol—a pH-stable 
Alexa 555 conjugate and a pH-sensitive fluorescein isothiocyanate 
(FITC) conjugate. The fluorescence intensity ratio between FITC and 
Alexa 555 was measured from internalized vesicles at different time 
points and compared with a pH-standard curve that was prepared in 
the same live assay. The pH of EV1-induced α2-MVBs after 6 h de-
creased to a slightly acidic pH of 6.8 (Figure 5A). Without EV1, the 
pH of endosomes after antibody-induced clustering was 6.9 and 6.5 
after 3 and 8 h, respectively. As a control for normal vesicle acidifica-
tion in the lysosomal pathway, we performed a similar experiment 
for epidermal growth factor receptor (EGFR), which is targeted to 
lysosomes for degradation upon stimulation with 100 ng/ml EGF. 
For the assay we used an antibody against the luminal domain of 
EGFR that does not interfere with EGF binding. EGF stimulation 
for 1, 2, and 4 h showed EGFR in more acidic structures, with pH 
between 5.2 and 5.5 (Figure 5A). Bafilomycin treatment of EGFR-
containing endosomes or EV1-induced α2-MVBs increased the pH 
to neutral values as expected.
Because bafilomycin treatment had some effect on the intraen-
dosomal pH, we also tested its effect on both infectivity and cargo 
characteristics. Furthermore, after 6 h, structures occasionally with 
less clearly defined ILVs or inner material and less conspicuous limit-
ing membrane were observed, suggesting that some sort of degra-
dation may occur inside α2-MVBs.
The early time points showing tubulovesicular structures were 
also characterized by confocal labeling for early endosomal marker 
(EEA1; Figure 4A and Supplemental Figure S1C). EV1 did not co-
localize with EEA1 after 5 or 15 min. The 30-min (Figure 4A) and 
1- and 2-h (Supplemental Figure S1C) time points were also la-
beled with late endosomal/lysosomal markers CD63, Lamp-1, and 
Rab7. None of these markers showed any colocalization with EV1 
or α2β1 integrin.
A more careful, quantitative measurement of the colocalization 
was performed for the time points between 2 and 6 h with Lamp-1 
and CD63. These measurements showed only random back-
ground colocalization (<10%) with internalized EV1 (Figure 4B). 
Similarly, cation-independent mannose-6-phosphate receptor 
(CI-MPR), which is located mainly in the trans-Golgi network and 
late endosomes, showed negligible colocalization (<10%) with α2 
integrin antibody at 1, 2, or 6 h after clustering (Supplemental 
Figure S1D). Furthermore, Rab7 showed no significant colocaliza-
tion with internalized α2 integrin between 1 and 6 h of clustering 
(Figure 4B), and no colocalization was found with 1,1’-dioctade-
cyl-3,3,3’,3’-tetramethylindocarbocyanine–low-density lipopro-
tein (Dil-LDL) internalized to lysosomes (Supplemental Figure S1E). 
On the basis of these data, we conclude that the α2-MVBs created 
by EV1 or antibody clustering are distinct from the endosomes 
along the clathrin-dependent pathway and do not interact with 
lysosomes.
FIGURE 3: EM images of endosomes triggered after α2β1 integrin clustering. Internalization for shorter time periods—
for example, 15 min—shows structures that have tubular extensions and vesicular parts without clear ILVs. ILVs grow 
continuously during internalization, and after 30 min >45% of the structures show several ILVs. The majority of the 
structures after 2 h and later are MVBs with a high number of ILVs. After 6 h, the number of clearly defined ILVs seemed 
to have decreased, and for some structures the limiting membrane is also less conspicuous (lower right). Integrin was 
labeled on the plasma membrane with specific primary antibodies, followed by secondary antibodies and protein A gold 
(10 nm). Bars, 200 and 500 nm.
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inhibitors did not have any effect on the degradation of α2-
conjugated HRP (Figure 6A). Furthermore, neither drug could block 
EV1 infection, further suggesting that proteasomal activity was not 
involved in α2-MVB function (Figure 6B).
Another form of degradation is autophagy. It depends on cal-
pains, since in calpain-deficient cells autophagy is impaired and 
lysosomal activity is reduced (Demarchi et al., 2006). The EV1-re-
lated viruses coxsackieviruses B3 and B4 have been shown to use 
autophagosomes in their replication (Wong et al., 2008; Yoon et al., 
2008), and both viruses need calpains for their infection (Upla et al., 
2008; Yoon et al., 2008). Thus we checked the connection of EV1 
and α2 integrin to autophagosomes by overexpressing the au-
tophagosomal marker LC3–green fluorescent protein (GFP). Infec-
tivity measurements showed that LC3-GFP overexpression did not 
promote, but rather inhibited, EV1 infection compared with GFP-
transfected control cells (Figure 6C). We also determined the amount 
of LC3-GFP–positive structures of EV1-infected and control cells 
and found that EV1 infection did not increase the amount or size of 
LC3-GFP structures (Figure 6D), in contrast to coxsackievirus B3, 
which increased the number and size of these structures (Wong 
et al., 2008). In addition, we did not detect any significant colocal-
ization between LC3 and α2 integrin, suggesting that α2-MVBs 
are not associated with the autophagosomal system (Figure 6E). 
Although these data do not conclusively rule out autophagocytosis, 
they suggest that EV1 does not need autophagosomes in its 
degradation. We added bafilomycin at different time points p.i. and 
allowed the infection to proceed until 6 h. We found that bafilomy-
cin had an effect on EV1 infection if administered during early phase 
of infection. When bafilomycin was added 2 h p.i., the effect was no 
longer significant, suggesting that the early entry phase, possibly 
virus uncoating, was sensitive for the bafilomycin effect (Figure 5B). 
However, later, when the α2-MVBs are known to be fully matured as 
judged by electron microscopy and the structures are about to open 
for genome release to the cytoplasm, pH no longer played a role in 
EV1 infection.
We also measured the effect of bafilomycin on α2 integrin deg-
radation after clustering with antibodies between 2 and 6 h. The 
results showed that bafilomycin had a small inhibitory effect on the 
degradation (Figure 5C). The results, taken together, thus suggest 
that the EV1-induced α2-MVBs do not require extensive acidifica-
tion of the structures for late stages of infection and for down-regu-
lation of α2 integrin.
Connection to proteasomal or autophagosomal degradation
Because there was no significant connection of α2 integrin degrada-
tion or EV1 infection to the lysosomal pathway and degradation, we 
tested the effect of two well-characterized proteasomal inhibitors, 
lactacystin and bortezomib, on α2 integrin–associated cargo degra-
dation. Measurements of integrin-conjugated horseradish peroxi-
dase (HRP) signal after 6 h of internalization showed that these 
FIGURE 4: The integrin internalization pathway has no significant association with the acidic clathrin-dependent 
pathway. (A) Colocalization of the early endosomal marker EEA1 (green) with EV1 after 5 min and of the classic late 
endosomal/lysosomal markers CD63 and Lamp-1 (green) with EV1 (red) and Rab7 (green) with α2 integrin (red) after 
30 min of internalization. Quantifications of colocalization of (B) EV1 with Lamp-1 and CD63 and (C) Rab7 (green) with 
α2 integrin for later time points were done from confocal single sections of single cells using a colocalization tool in the 
BioImageXD software. Altogether 30 cells from three independent experiments were analyzed. Results are shown as 
mean values ± SE. Bars, 10 μm.
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infection process and that EV1 infection it-
self does not cause appearance of enlarged 
LC3-GFP structures (Supplemental Figure 
S2A). Finally, infectivity measurements after 
extended serum-free starvation of cells 
showed lowered infectivity compared with 
higher serum concentrations (Figure 6F). 
Given that serum starvation is known to 
drive autophagocytosis, this result is also in 
line with the suggestion that autophagocy-
tosis may not be crucial for EV1 infection 
and that autophagocytosis is not associated 
with this integrin internalization pathway.
Degradation of integrin cargo depends 
on calpains
We showed previously that the neutral pro-
teases calpains are essential for EV1 infec-
tion and that they are associated with inter-
nalized EV1 and α2β1 integrin (Upla et al., 
2008). Therefore we decided to test whether 
they were also contributing to the degrada-
tion of clustered α2 integrin. We first tested 
the involvement of calpains during the anti-
body-induced clustering with Alexa conju-
gate in confocal microscopy (Figure 7A). In 
normal clustering (=control), integrin signal 
accumulated during 2 h in perinuclear vesi-
cles, and the signal gradually diminished, so 
that after 24 h almost all signal was gone. 
This was partially reversed by the pan inhibi-
tor of calpains calpeptin. Leupeptin, which 
inhibits lysosomal degradation, showed 
only a modest inhibition of α2 degradation.
In addition to fluorescence intensity 
measurements, we performed an analogous 
experiment using HRP conjugate in cluster-
ing. These data also show that in control 
cells the HRP signal decreased by roughly 
60% after 6 h, and it was practically unde-
tectable after 24 h (Figure 7B). However, 
calpeptin, but not leupeptin, efficiently in-
hibited the degradation of the HRP cargo. In 
addition to calpeptin, specific calpain 1 and 
2 inhibitors also inhibited α2 integrin down-
regulation (Supplemental Figure S2B). This 
further suggests a role of both calpain-1 and 
calpain-2 in the degradation process. The 
inhibitory effect was specific to calpain in-
hibitors since other protease inhibitors had 
no effect on degradation (Supplemental 
Figure S2C). Because calpains seemed to 
promote the degradation of the HRP signal, 
we then wanted to verify whether α2β1 inte-
grin could also be degraded by calpain pro-
teases in vitro. We incubated α2 integrin, 
immunoprecipitated from metabolically la-
beled cells, with calpain-1 or calpain-2 for 5 
and 60 min (Figure 7C). The results showed 
that both types of calpains were able to de-
grade α2 integrin in vitro, with increasing 
degradation following 60 min of incubation. 
FIGURE 5: Significant acidification is not required for α2 integrin degradation and EV1 infection. 
(A) pH of α2-MVBs after α2 integrin clustering with EV1, A211E10, and EGFR ± bafilomycin was 
measured from live SAOS-α2β1 cell images as described in Materials and Methods. The ratio 
between goat anti–rabbit/mouse FITC and goat anti–rabbit/mouse Alexa 555 signal, bound at 
1:1 stoichiometric ratio to anti-EV1 antibody on the plasma membrane before internalization, 
was measured from each time point and compared with the pH standard curve. The pH 
standard curve was acquired by measuring ratios of virus-bound dyes in the presence of 
different pH buffer solutions supplemented with nigericin (20 μM). The results were analyzed 
from 15 to 30 confocal sections, and the experiments were repeated two (EV1) to four (α2 
integrin) times (±SE). (B) Effect of 50 nM bafilomycin on EV1 infection rate was determined. The 
drug was added 15 min, 30 min, 1 h, or 2 h p.i. Infection was calculated from >750 cells from 
three individual experiments (±SE). Statistical significance was tested with Student’s t test 
(***p < 0.001). (C) The effect of bafilomycin (50 nM) on α2 integrin fluorescence intensities was 
measured between 2 and 6 h of internalization. Quantification was done from confocal sections 
of 30 microscope images containing at least 20 cells each from three independent experiments 
(±SE). Statistical significance was tested with Student’s t test (*p < 0.05, ***p < 0.001).
FIGURE 6: Connection of α2β1 integrin pathway to proteasomal and autophagosomal 
degradation. Effect of proteasome inhibitors lactacystin (10 μM) and bortezomib (0.7 μM), on 
(A) the activity of α2 integrin–conjugated HRP and (B) EV1 infection. For EV1 infectivity, 
calculations of >750 cells from three independent experiments were analyzed. Results are shown 
as mean values (±SE). C) Infection rate in SAOS-α2β1 cells transfected with GFP (control) or 
LC3-GFP was counted from at least 750 cells and three independent experiments. Results are 
shown as averages (±SE). (D) The amount of LC3-GFP structures per cell at 3 h p.i. was calculated 
in noninfected (control) and infected cells. Altogether 200 cells were calculated from three 
independent experiments, and results are shown as mean values (±SE). (E) Quantification of 
colocalization between clustered and internalized α2 integrin and the transfected autophagosomal 
marker LC3-GFP was performed. Quantification was done from single confocal sections with the 
colocalization tool in the BioImageXD software. Calculations were done from 30 cells from three 
independent experiments (±SE). (F) Infectivity of EV1 was tested after overnight serum-free 
starvation or during full medium conditions. A minimum of 750 cells was counted from three 
independent tests. Results are presented as average of three experiments (±SE).
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that calpeptin could inhibit integrin degra-
dation. The ability of calpain inhibitors to 
block α2 integrin degradation was not due 
to inhibition of the formation of α2-MVB 
structures. This was evident because admin-
istration of the calpain inhibitors at 2 h 
postinternalization was still sufficient to in-
hibit integrin degradation (Supplemental 
Figure S2D).
Calpains are active and present in 
α2-MVBs
Because calpains are known to be localized 
in the cytosol and bound to their substrates 
also on the membranes, we wanted to study 
in greater detail how these cytosolic neutral 
proteases are associated with α2-MVBs. We 
first performed immunoprecipitation of 
α2β1 integrin using different approaches. 
Immunoprecipitation of α2 integrin with α2 
integrin polyclonal antibody (pAb) from 
both unclustered and clustered cells after 
2 h of internalization showed a significant 
fraction of calpain-1 in the immunoisolates 
(Figure 8). The amount of calpain-1 associ-
ated with α2 integrin isolated from the total 
integrin pool did not change due to cluster-
ing, suggesting that clustering itself caused 
no major change in the amount of calpain-1 
associated with total α2 integrin. Similar 
data were obtained with two different β1 in-
tegrin antibodies in conjunction with EV1 
infection. Of interest, EV1-induced cluster-
ing promoted coprecipitation predomi-
nantly with the smaller, possibly activated 
form of calpain-1, whereas in the lysate, the 
80-kDa form of calpain was most abundant. 
Finally, as the third approach, immunopre-
cipitation was performed using the cluster-
ing rabbit anti-mouse antibody that was 
bound on the integrin antibodies on the 
plasma membrane before internalization. 
Immunoprecipitation of this clustering anti-
body thus precipitated only the integrin 
clusters that were internalized to the cyto-
plasm during 15 min and 2 h. The results 
show that calpain-1 was also enriched with 
integrin clusters after 2 h of clustering, prov-
ing that calpain was present in the internal-
ized α2-MVBs. Taken together these results show that both the clus-
tered and unclustered α2β1 integrin associates with calpain-1 and 
further suggest that, after clustering, a higher amount of coprecipi-
tated calpain-1 is associated with α2β1 integrin clusters at a later 
time point.
In line with the observed association of calpains with internal-
ized α2β1 integrin, we detected low but significant labeling of 
calpain-2 in α2-MVBs after 2 and 6 h in thin, frozen sections 
(Figure 9A). Careful quantitation of small gold particles represent-
ing calpain label in α2-MVBs against labeling with control immu-
noglobulin G (IgG) showed that α2-MVBs after both 2 h (p < 0.005) 
and 6 h (p < 0.0002) were significantly labeled with calpain-2. The 
labeling showed that calpain was present inside the α2-MVBs. 
The degradation was seen as the disappearance of the ∼160-kDa α2 
integrin band and the ∼130-kDa β1 integrin band. Simultaneously, a 
small band of ∼27 kDa accumulated with calpain induced degrada-
tion but was absent in calpeptin-treated lysates. This calpain-in-
duced degradation of α2 integrin was inhibited when the specific 
calpain inhibitor calpeptin was present.
The inhibitory effect of calpeptin on integrin degradation was 
also tested after immunoprecipitation of integrins clustered and in-
ternalized from the plasma membrane (Figure 7D). Immunoprecipi-
tation of the clusters via the clustering antibody showed typically 
lower amount of α2 integrin after 6 h and very little after 24 h. Im-
munoprecipitation of the clusters in the presence of calpeptin 
showed more α2 integrin precipitated after 6 and 24 h, suggesting 
FIGURE 7: Calpain inhibitor blocks degradation of α2 integrin. (A) Influence of leupeptin and 
calpeptin on the fluorescence intensity of integrin-conjugated Alexa 488 after α2 integrin 
clustering and internalization in SAOS-α2β1 cells. Fluorescence signal was quantified from single 
confocal sections. Altogether 30 cells from three independent experiments were calculated 
(±SE) Statistical significance was tested with Student’s t test (***p < 0.001). Bars, 10 μm. 
(B) Effect of leupeptin and calpeptin on the amount of HRP activity, conjugated to clustering 
secondary antibody, was measured. The amount of HRP was measured from cell lysates. Cells 
were pretreated overnight with DMSO (control) and leupeptin (50 μg/ml) or for 1 h with 
calpeptin (50 μM). Results are averages of three independent experiments (±SE). Statistical tests 
were done with Student’s t test (**p < 0.01, ***p < 0.001). (C) Metabolically labeled and 
immunoprecipitated α2 integrin samples were treated with calpain-1 or calpain-2 for 5 and 
60 min at 37°C. In control samples, the calpain inhibitor calpeptin was added before calpain 
enzymes. Densitometric quantitation of α2 integrin levels was done with ImageJ. 
(D) Immunoprecipitation of surface-labeled α2 integrin via the clustering antibody introduced 
before internalization for 0, 6, and 24 h with or without the presence of calpeptin. α2 integrin 
was revealed on the blot by immunolabeling.
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labeling with collagen showed that internalized α2β1 integrin colo-
calized at least partially with collagen. The colocalization was more 
obvious when more integrin also was internalized, that is, after 6 h. 
However, it is striking that, after 24 h, the cytoplasmic integrin vesi-
cles disappeared and the overall amount of α2β1 integrin seemed 
to have dropped to levels lower than that in cells grown on plastic. 
This suggested that the integrin might have undergone degrada-
tion. In addition to steady-state labeling of α2β1 integrin, we also 
followed α2β1 integrin labeled on the cell surface with monovalent 
Fab fragment and fluorescent conjugate 2 h after plating on colla-
gen. At 2 h after labeling (4 h in total after plating on collagen) the 
label was only detected in cytoplasmic vesicles, in contrast to con-
trol Fab labeling on plastic, which showed more plasma membrane 
labeling (Figure 10C). Treatment of the cells with calpeptin caused 
the accumulation of integrin with collagen into cytoplasmic vesicles 
with no apparent loss of integrin signal in cytoplasmic vesicles after 
24 h (Figure 10A). Of interest, colabeling of the collagen and Lamp-
1, the late endosomal/lysosomal marker, showed no colocalization 
after 6 or 24 h, suggesting that, similar to internalized α2β1 integrin, 
collagen also did not enter acidic lysosomal structures during the 
first 24 h (Supplemental Figure S3B). Treatment of the cells with 
calpeptin did not cause any change in the colocalization of collagen 
with Lamp-1.
These results suggest that collagen uptake induces a compara-
ble internalization and enhanced turnover of α2β1 integrin to integ-
rin clustering with EV1. Furthermore, internalized α2β1 integrin co-
localizes at least partially with endosomal collagen, and this 
colocalization is enhanced when integrin turnover is blocked with 
calpain inhibition.
DISCUSSION
Integrins mediate cell attachment to its environment by binding to 
ECM components, such as collagen, fibronectin, vitronectin, and 
laminin (van der Flier and Sonnenberg, 2001). Especially in migrat-
ing and proliferating cells, disintegration and formation of adhesion 
sites are crucial. For continuous turnover of focal adhesions, integ-
rins are recycled through the recycling pathways involving early and 
recycling endosomes that are regulated by rab4/5 and rab11/Arf6/
Arf1/Rab5/Rab25/Rab21, respectively (for reviews see Jones et al., 
2006; Pellinen and Ivaska, 2006). In addition, ligand-bound integrins 
may be targeted to the lysosomes for degradation (Lobert et al., 
2010). In this study we show that α2β1 integrin clustering by EV1 or 
by antibodies triggers endocytosis of virus and the receptor to spe-
cialized perinuclear α2 integrin–rich multivesicular bodies, α2-MVBs. 
This EV1-triggered integrin traffic route is markedly distinct from the 
previously described integrin traffic routes for several reasons: 1) the 
endocytosed integrin is not recycled back to the plasma membrane; 
2) the integrin is not targeted to lysosomes for degradation; and 3) 
the integrin degradation occurs in less acidic α2-MVBs, which are 
biochemically distinct from conventional MVBs.
Proteins of the plasma membrane are normally down-regulated 
in lysosomes by acidic hydrolases. Those include growth factor 
receptors, such as EGFR or vascular endothelial growth factor re-
ceptor 2, which are guided to acidic late endosomes/lysosomes 
after stimulation (Futter et al., 1996; Falguieres et al., 2009; Bruns 
et al., 2010). EGF stimulation causes rapid proteolysis of EGFR, 
which is almost complete in 2 h (Burke et al., 2001; Salazar and 
Gonzalez, 2002; Sigismund et al., 2008). In contrast, α2 integrin 
down-regulation after clustering was a much slower process than 
classic lysosomal degradation. This is in line with our data showing 
that lysosomal degradation is not involved in α2 integrin down-
regulation.
Furthermore, the α2-MVB–associated calpain was active. The to-
tal calpain activity (detected with cell-permeable fluorogenic cal-
pain substrate 7-amino-4-chloromethylcoumarin, t-BOC-l-leucyl-
l-methionine amide [t-BOC]; Rosser et al., 1993) after α2 integrin 
clustering for 30 min and 2 h was close to the basal control activity 
in the cells (Figure 9B), in line with our earlier calpain measure-
ments using a different approach (Upla et al., 2008). However, al-
ready after 30 min and also later, at 2 h, the calpain activity was 
detected in the α2-MVBs in the cytoplasm, suggesting that redis-
tribution of cytoplasmic calpain occurred to α2 integrin–positive 
structures (Supplemental Figure S3A). Colocalization measure-
ments showed that ∼80% of the t-BOC label colocalized with α2 
integrin at 2 h p.i., suggesting that after integrin clustering, the 
majority of the highest calpain activity was localized to α2-MVBs 
(Figure 9C). Six hours of integrin clustering with or without EV1 
caused an increase of calpain activity (Figure 9B). According to the 
microscopy, this was due to the higher activity in α2-MVBs, but 
also in the cytoplasm, elevating the overall cellular activity above 
the basal activity. Treatment of the cells with calpeptin abolished 
calpain activation and, as expected, showed very little intensity 
when imaged with similar settings (Supplemental Figure S3A). In 
conclusion, these results demonstrate that active calpain is pres-
ent in the α2-MVBs after integrin clustering and internalization. 
Thus, clustering of α2 integrin induces its internalization into a 
nonrecycling, nonlysosomal endosomal compartment where the 
receptor is degraded by calpains.
Collagen uptake induces α2β1 integrin internalization 
and promotes calpain-sensitive turnover of integrin
Because it is very probable that viruses induce pathways that were 
originally developed for physiological ligands, we decided to study 
whether collagen type I has similar effects on α2β1 integrin distribu-
tion. Indeed, plating the cells on collagen type I caused redistribu-
tion of integrin to the cytoplasm (Figure 10). The number and size of 
the internalized vesicles seemed to increase from 2 to 6 h. Double 
FIGURE 8: Calpains are present in α2-MVBs. Immunoblot labeling of 
calpain-1 and α2 integrin from SAOS-α2β1 cell lysates (lys) or after 
immunoprecipitation was performed. Immunoprecipitation of total α2 
or β1 integrin pool from cell lysates with or without α2 integrin 
clustering was performed with polyclonal α2 integrin (pAb, ab1936) or 
monoclonal β1 integrin (mAb, 12G10, and Mab13) antibodies. A pool 
of clustered α2β1 integrins was specifically precipitated with the 
rabbit anti-mouse (r.a.m.) antibody that was used for clustering of the 
α2 integrin mAbs (MCA2025, A211E10, A2E). The 80-kDa and a 
smaller form of calpain-1 are indicated by arrows.
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tion, for example, after myocardial injury induced by increased 
Ca2+ in the cytoplasm (Matsumura et al., 2001). The maximal in-
crease in calpain activity using t-BOC was 1.38-fold compared 
with the basal calpain activity in myocardial cells, and α2 integrin 
clustering here caused a 1.39-fold increase after 6 h. Similarly, 
in another study with t-BOC, calcium release from ER caused a 
1.4-fold increase in calpain activity compared with basal activity 
(Rosser et al., 1993).
Studies with calpain inhibitors revealed that indeed calpains 
are essential for degradation of clustered α2 integrin. In addition, 
active calpains were colocalized with α2-MVBs in the cytoplasm, 
and calpain-1 was coimmunoprecipitated with clustered integrin. 
Calpains are cytosolic proteases that need Ca2+ and a neutral en-
vironment to be active (Goll et al., 2003; Suzuki and Sorimachi, 
1998). The increase of calpain activity that was found after integ-
rin clustering was in a similar range as found for calpain activa-
FIGURE 9: Calpains are present and active in α2-MVBs. (A) Calpain-2 antibody labeling of thin, frozen sections. The 
amount of small gold particles representing calpain label from 30 α2-MVB structures were counted and compared with 
labeling with control IgG. Calculated p values were p < 0.005 for 2 h and p < 0.0002 for 6-h samples. (B) t-BOC intensity 
was measured from the wide-field images after 30 min, 2 h, and 6 h of α2 integrin clustering and internalization with or 
without EV1. The change of intensities was compared with the basal calpain intensity in control cells (set to 100%). 
Intensity of t-BOC labeling was quantified from ∼300 cells from three independent experiments (±SE). Example images 
after integrin clustering (A211E10) for 6 h with or without EV1 are shown. In addition, control t-BOC labeling from 
control unclustered cells is shown (Ctrl). Bars, 10 μm. (C) Wide-field images of t-BOC labeling in cells after α2 integrin 
clustering for 2 h ± EV1. Colocalization of t-BOC with α2 integrin (t-BOC coloc) and α2 integrin with t-BOC (α2β1 coloc) 
was measured from wide-field images from ∼300 cells from three independent experiments. Some colocalized vesicles 
are highlighted by arrowheads. Bars, 10 μm.
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In this study we described an integrin down-regulation pathway 
that relies on calpains rather than lysosomal enzymes. Previously 
calpain was shown to contribute to down-regulation of β1 integrin in 
normal but not in cancer prostate cells in addition to lysosomal pro-
teolysis (Moro et al., 2004). Here we showed that calpains were ef-
ficiently precipitated together with clustered and unclustered α2 
and β1 integrins and were active in the internalized structures. Cal-
pains are known to be activated after ligand binding to integrin 
close to the plasma membrane (Fox et al., 1993; Carragher et al., 
1999). The coprecipitated calpain after 2 h was predominantly 
the smaller autolysed 78- or 76-kDa form of calpain-1, suggesting 
that during clustering and internalization calpains were indeed acti-
vated (Hathaway et al., 1982; Cong et al., 1989; Zimmerman and 
Schlae pfer, 1991; Schoenwaelder et al., 1997). Calpain autolysis has 
It is widely known that calpains regulate cell migration. Numer-
ous calpain substrates are involved in cell migration and adhesion. 
These include, for example, talin, spectrin, and FAK (Franco and 
Huttenlocher, 2005). In addition, integrin β cytoplasmic tails, includ-
ing β1 integrin, can be cleaved with calpain (Pfaff et al., 1999). Cal-
pains seem to have different kinds of roles in the regulation of adhe-
sion sites, cell spreading, and formation of protrusions (Franco and 
Huttenlocher, 2005; Lebart and Benyamin, 2006). Calpain inhibition 
has been shown to reduce both β1 and β3 integrin–mediated cell 
migration by stabilizing cytoskeletal linkages and reducing detach-
ment of adhesions at cell rear (Huttenlocher et al., 1997; Palecek 
et al., 1998). On the other hand, calpain can also induce the forma-
tion of early integrin clusters, which contain Rac-binding protein(s), 
calpain, and calpain-cleaved β3 integrin (Bialkowska et al., 2000).
FIGURE 10: α2β1integrin distribution in cells plated on collagen. (A) Steady-state distribution of integrin (red) and 
collagen type I (green) after 2, 6, and 24 h with or without calpeptin. Merged images of integrin and collagen are below, 
with details shown in blow-up images. (B) Control integrin labeling of cells cultivated on plastic. Images in A and B were 
scanned with similar confocal intensity settings for easier comparison. (C) Surface labeling of α2β1 integrin by A211E10 
antibody, followed by monovalent goat anti–mouse Fab549 DyLight (red) on cells cultivated on plastic (left) or on 
collagen coating (right) for 2 h. After surface labeling, cells were further incubated for 2 h, fixed, and labeled for 
collagen (green). Bars, 10 μm.
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recruitment of crucial factors or to the release of inhibitory factors 
and higher activation of calpains in the α2-MVBs. We showed re-
cently that expression of the dominant-negative Vps4, which de-
creases the formation of ILVs in the MVBs, leads to reduced turnover 
of integrin in the α2-MVBs, suggesting further that ILVs may be im-
portant in the calpain-dependent turnover of integrins (Karjalainen 
et al., 2011). To have full understanding of this process of calpain 
activation in α2-MVBs more biochemical and structural studies are 
needed.
It is surprising that exposure of cells on collagen—the physiolog-
ical ligand of α2β1 integrin—induced collagen and integrin uptake 
to cells, resembling the effects of antibody clustering or EV1 infec-
tion. The integrin was targeted to cytoplasmic vesicles, leading to 
calpain-sensitive turnover during 24 h. This suggests that EV1 may 
have evolved to use a similar pathway that is elicited during uptake 
of soluble collagen. Previously the urokinase plasminogen activator 
receptor–associated protein (uPARAP)/Endo180 was shown to be 
the crucial receptor for collagen uptake, whereas function-blocking 
antibodies against β1 integrins did not interfere with collagen up-
take (Engelholm et al., 2003). Despite the dispensable role of integ-
rins in collagen uptake, integrin clustering upon collagen binding 
clearly can trigger integrin uptake and may be relevant for regulat-
ing integrin turnover. Further studies are needed to understand in 
detail the relationship between the cellular collagen uptake path-
way and the clustering-induced integrin internalization pathway de-
scribed here.
In conclusion (Figure 11), we suggest that after clustering of 
α2β1 integrin on the plasma membrane, integrin is internalized to 
the perinuclear region and accumulated in α2-MVBs, as we previ-
ously showed (Karjalainen et al., 2008). Integrin is not recycled back 
to the plasma membrane, in contrast to the slow recycling of the 
been associated with activation of calpains 
(Inomata et al., 1986; Cong et al., 1989; Baki 
et al., 1996; Suzuki and Sorimachi, 1998). 
However, autolysis is not essential for calpain 
catalytic activation since intact calpains can 
also be active, but autolysis is thought to de-
crease the need of calcium for calpain acti-
vation (Imajoh et al., 1986; Elce et al., 1997; 
Suzuki and Sorimachi, 1998; Goll et al., 
2003). In addition, other factors—for exam-
ple, phospholipid binding, regulation by cel-
lular inhibitors, and the phosphorylation sta-
tus of calpains—have been suggested to 
contribute to local activation of calpains 
(Franco and Huttenlocher, 2005). High cal-
cium requirement for calpain activation may 
have been developed during evolution as a 
safety measure to inhibit unwanted proteol-
ysis, and, for the same reason, it has been 
suggested that calpains would normally act 
with half-maximal efficiency.
What is the mechanism of calpain-medi-
ated degradation of the integrins? Calpains 
are not normally accessible to the N-termi-
nal luminal domain of α2β1 integrin, which 
was evidently degraded after clustering and 
internalization. Therefore, during the inter-
nalization process, in the forming α2-MVBs, 
calpains need to gain better access to the 
integrin substrate. Calpeptin did not pre-
vent the formation of α2-MVBs, suggesting 
that the inhibition of degradation does not occur through a block in 
structural morphogenesis. The observation that the integrin struc-
tures were clearly less acidic than late endosomes/lysosomes may 
be one crucial factor for efficient calpain action. This is also demon-
strated by the fact that EV1-triggered structures showed more-en-
hanced integrin degradation and remained in slightly higher pH 
than structures triggered by antibody-induced clustering. Calpains 
are known to associate with α2β1 integrin C-termini on the plasma 
membrane. Our EM immunolabeling results suggested that during 
the biogenesis of α2-MVBs calpains are associated with endosomal 
limiting membrane, and they may be partially targeted to the form-
ing intraluminal vesicles, as they remain bound to α2 integrin. Our 
studies indicated that also the luminal domains of integrins, not only 
the beta tail (Pfaff et al., 1999), undergo degradation by calpains. 
Viruses are known to cause endosomal membrane ruptures, includ-
ing another picornavirus major group rhinovirus, HRV14 (Schober 
et al., 1998), and human adenovirus after binding to its integrin re-
ceptor αVβ5 (Wickham et al., 1994; Greber et al., 1996). Our pre-
liminary results suggest that increased permeability of α2-MVBs and 
ruptures of intraluminal vesicles are detected during EV1 entry by 
a novel confocal microscopy assay and cryo–electron tomography, 
respectively (Soonsawad, Upla, Weerachatyanukul, Rintanen, 
Poon, Cheng, Espinoza, McNerney, Huser, Hwang, Milla, Tripathi, 
Pisitchaiyakul, Furukawa, Kawasaki, Vahlne, Marjomäki, Cheng, un-
published results). Calpains may thus enter the endosomal lumen 
through the formed breakages. In the endosomal lumen the Ca2+ 
concentration is supposedly higher than in the cytoplasm, thus lead-
ing to higher calpain activation. This is in line with our fluorescent 
t-BOC activity labelings, which suggested higher activity in large 
clusters, especially after 6 h of internalization. One can speculate 
that integrin clustering on the plasma membrane may lead to 
FIGURE 11: Integrin clustering induced a down-regulation pathway. After clustering of α2β1 
integrin on the plasma membrane with EV1 or antibodies, integrin is internalized to the 
perinuclear region and accumulates in α2-MVBs. Integrin is not recycled back to the plasma 
membrane, in contrast to the slow recycling of the unclustered α2 integrin. The perinuclear 
α2-MVBs are degradative structures and distinct from lysosomes, autophagosomes, and 
proteasomes. Instead, degradation of integrin in α2-MVBs is promoted by neutral proteases—
calpains that are present and activated in these structures.
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45 min on ice. Cells were washed extensively and incubated with a 
clustering secondary antibody for 45 min. In nonclustering controls 
a monovalent Fab fragment of IgG was used instead. After washing, 
cells were incubated in DMEM containing 10% serum at +37°C to 
allow internalization. To measure the degradation of α2 integrin, 
clustering was done with MCA2025 and goat anti–mouse Alexa 555 
antibodies. After fixation and permeabilization, α2 integrin was la-
beled with biotinylated A211E10 and streptavidin–Alexa 488.
Drug treatments
Cells were preincubated for 30 min with 10 μM lactacystin or 0.7 μM 
bortezomib before EV1 attachment or antibody clustering. Drugs 
were also present in the incubation medium. Bafilomycin (50 nM) 
was either added 15 min, 30 min, 1 h, or 2 h p.i. (infectivity testing) 
or 2 h p.i. (pH measurements) to the cells.
Six protease inhibitors were used: antipain (500 μM), aprotinin 
(1 μM), elastatinal (250 μM), leupeptin (108 μM), soybean trypsin 
inhibitor (75 μM), and calpeptin (50 μm). DMSO was used as control. 
Subconfluent SAOS-α2β1 cells were preincubated in 10% DMEM 
with drugs for 1 h (except for leupeptin overnight) before clustering, 
and inhibitor was also present in the incubation medium. α2 integrin 
was clustered as described. After each time point cells were lysed 
on ice with lysis buffer (150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 
25 mM Tris-HCl, pH 7.4) containing 100 mM octyl-β-glucopyranoside. 
From each sample the amount of total proteins was measured with 
Bradford assay. The amount of HRP conjugated to secondary anti-
body (Bio-Rad) was detected from color reaction, which was induced 
with reaction solution (0.0003% H2O2, 0.1% Triton X-100, 10 mg o-
diniazidine, 0.05 M NaPO4, pH 5.0). Absorbance of samples was 
measured at 405 nm, and the results were compared with HRP stan-
dards. Background peroxidase activity was removed from the 
results.
t-BOC assay
t-BOC substrate was added at 50 μM concentration on clustered 
cells 20 min before fixation and embedding in Mowiol. Cells were 
imaged with a Cell Observer wide-field microscope (Zeiss, Jena, 
Germany) using a 365-nm light-emitting diode for excitation of 
t-BOC and 590 nm for α2 integrin labeled with Alexa 594.
Collagen coating assay
Coverslips were coated with 5 μg/ml collagen (Vitrogen 100) in 
phosphate-buffered saline (PBS) on ice and incubated overnight 
at +4°C. Cells were plated on coated coverslips in 0.5% bovine se-
rum albumin (BSA)–DMEM and incubated at +37°C 2, 6, or 24 h 
before fixing with 4% paraformaldehyde (PFA). In Fab-fragment la-
beling experiments, after 2 h of incubation, cells were placed on ice, 
and integrin was labeled first with A211E10 antibody and then with 
goat anti-mouse Fab fragment DyLight 549. Then incubation was 
continued for 2 h at +37°C.
Metabolic labeling
Cells were pulsed for 24 h in serum-free DMEM with 50 μCi/ml of 
[35S]methionine and cysteine labeling mix. After pulse, cells were 
chased for 0, 24, 48, 72, or 96 h in 10% fetal calf serum (FCS)–DMEM 
with 0.16 mg/ml nonradioactive methionine. Cells were scraped, 
and pellet was dissolved in IP buffer (150 mM NaCl, 1 mM CaCl2, 
1 mM MgCl2, 25 mM Tris-HCl, pH 7.4) containing 0.1 M octyl-β-d-
glucopyranoside for 30 min on ice. α2 integrin antiserum was added 
to cleared supernatant and incubated overnight at +4°C and then 
precipitated with PA–Sepharose. When the precipitates were treated 
with calpain enzymes, calpain-1 (10 μg) or calpain-2 (5 μg) was 
unclustered α2 integrin. The perinuclear α2-MVBs are degradative 
structures and distinct from lysosomes, autophagosomes, and 
proteasomes. Instead, degradation of α2 integrin in α2-MVBs is 
promoted by neutral proteases—calpains—which are accumulated 
and activated in these structures.
MATERIALS AND METHODS
Cells, viruses, antibodies, and reagents
Experiments were performed using a human osteosarcoma cell line 
overexpressing the α2 integrin subunit (SAOS-α2β1 cells, clone 45; 
Ivaska et al., 1999). EV1 (Farouk strain; American Type Culture Col-
lection, Manassas, VA) was produced and purified as described pre-
viously (Marjomäki et al., 2002). The following polyclonal antibodies 
were used: rabbit antisera against purified EV1 (Marjomäki et al., 
2002), calpain-2 (Sigma-Aldrich, St. Louis, MO), α2 integrin (a gift 
from Jyrki Heino, University of Turku, Turku, Finland), α2 integrin 
(AB1936; Millipore, Billerica, MA), CI-MPR (Marjomäki et al., 1990), 
Rab7 (a gift from Jean Gruenberg, University of Geneva, Geneva, 
Switzerland), collagen type I (Cedarlane Laboratories, Burlington, 
NC), Alexa 488 (Invitrogen, Carlsbad, CA), mouse IgG (Sigma-
Aldrich), and rat IgG (Jackson ImmunoResearch Laboratories, West 
Grove, PA). In addition, goat anti–rabbit or anti–mouse IgG conju-
gated with Alexa 488, Alexa 555, Alexa 594, fluorescein (Invitrogen), 
or HRP (Bio-Rad Hercules, CA) and goat anti–mouse or anti–rabbit 
Fab fragment DyLight 549 (Jackson ImmunoResearch) were used. 
Monoclonal antibodies against α2 integrin (A211E10 [from Fedor 
Berditchevski, Institute of Cancer Studies, Birmingham, United King-
dom] and MCA2025 [AbD Serotec, Raleigh, NC]), β1 integrin (12G10 
[Abcam, Cambridge, MA] and Mab13 [BD Biosciences PharMingen, 
San Diego, CA]), CD63 (Zymed, San Francisco, CA), Lamp-1 (Santa 
Cruz Biotechnology, Santa Cruz, CA), EGFR (Thermo Scientific, 
Waltham, MA), EEA1, and calpain-1 (Sigma-Aldrich) were used.
Aprotinin, elastatinal, leupeptin, soybean trypsin inhibitor, anti-
pain, EGF, and octyl-β-glucopyranoside were all purchased from 
Sigma-Aldrich. Calpeptin, lactacystin, bafilomycin, nigericin, and 
calpain-1 and -2 inhibitors were from Calbiochem (La Jolla, CA). 
FuGENE 6 reagent was purchased from Roche (Indianapolis, IN), 
t-BOC substrate and streptavidin–Alexa 488 from Invitrogen, and 
bortezomib from LC Laboratories (Woburn, MA). LC3-GFP was a gift 
from Eeva-Liisa Eskelinen (University of Helsinki, Helsinki, Finland). 
Supersignal chemiluminescent substrate was purchased from Pierce 
Thermo Fisher Scientific (Rockford, IL), Vitrogen 100 from Angiotech 
BioMaterials (Palo Alto, CA), PA-Sepharose from GE Healthcare 
(Piscataway, NJ), and Easytag [35S]methionine and cysteine labeling 
mix and En3hance solution from PerkinElmer (Waltham, MA). 
Dil-LDL was kindly provided by Seppo Ylä-Herttuala (University of 
Eastern Finland, Kuopio, Finland).
Viral infection and integrin clustering experiments
EV1 was used at multiplicity of infection of 100 in all experiments. 
EV1 was first bound to cells for 1 h on ice in DMEM containing 1% 
serum; cells were washed extensively and then put to +37°C in 
DMEM containing 10% serum to allow internalization. For infectivity 
testing, infection was allowed to proceed for 6 h. To test the effect 
of starvation on EV1 infectivity, cells were grown without serum 
overnight, and virus binding and following incubation were done in 
serum-free DMEM. In colocalization assays, virus was prelabeled 
with sequential treatments with anti-EV1 antibody and goat anti-
rabbit Alexa antibody on ice before internalization. Prelabeling of 
EV1 has been verified not to affect infectivity. In the α2β1 integrin 
antibody clustering protocol, monoclonal antibody A211E10 or 
MCA2025 against α2 integrin was bound to cells in 1% DMEM for 
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and imaged on confocal microscopy. Intensity of fluorescence 
was analyzed from the confocal z-stacks with BioImageXD (a 
free, open source software package; Kankaanpää et al., www 
.bioimagexd.net) segmentation tools.
Recycling was also evaluated using electron microscopy. SAOS-
α2β1 cells were first treated with anti–α2 integrin antibody 
(Α211E10), then with rabbit anti–mouse IgG (Sigma-Aldrich), and 
finally with 10 nm of PA-gold prepared according to Slot and Geuze 
(2007), all for 45 min on ice, followed by extensive washes. The cells 
were then transferred to 37°C and incubated for 2 or 24 h in 10% 
DMEM. The cells were fixed in 2.5% glutaraldehyde in 0.1 M phos-
phate buffer (pH 7.4) for 1 h, postfixed with 1% osmium tetroxide for 
1 h in the same buffer, dehydrated in ethanol, stained with uranyl 
acetate, and embedded with LX-112.
Intraendosomal pH measurement
Intraendosomal pH measurements were conducted as previously 
described (Karjalainen et al., 2011). Briefly, EV1 was first bound to 
SAOS-α2β1 cells on ice, followed by incubation with anti-EV1 anti-
body. Then equal amounts of goat anti–rabbit fluorescein and goat 
anti–rabbit Alexa 555 were bound to cells on ice and the cells moved 
to 37°C for 4–6 h. In antibody clustering, anti-integrin (A211E10) 
antibody and goat anti–mouse fluorescein and Alexa 555 were 
used. Bafilomycin (50 nM) was added on cells after 2 h. Cells were 
kept at +37°C in the Olympus FluoView 1000 confocal setup under 
CO2-independent medium (Life Technologies, Carlsbad, CA) con-
taining 10% serum. Confocal sections were taken at 4 and 6 h in the 
absence or presence of bafilomycin. For the pH titration curve, cell 
membranes were permeabilized with 20 μM nigericin in pH stan-
dard buffer solutions (150 mM KCl, 5 mM glucose, and 15 mM Tris, 
pH 7.0) or 15 mM 2-(N-morpholino)ethanesulfonic acid, pH 5.5, 6.0, 
and 6.5). Altogether 30 cells in each case from two independent 
tests were scanned, and the ratio of fluorescein/Alexa 555 was de-
termined for each section. When pH of EGFR was measured, EGFR 
antibody against extracellular domain and equal amounts of goat 
anti–mouse fluorescein and Alexa 555 were bound sequentially on 
ice in serum-free conditions. EGF, 100 ng/ml, was used to internalize 
receptor at +37°C in serum-free, CO2-independent medium. Cells 
were imaged with the confocal setup of the Zeiss LSM510.
Electron microscopy
For visualizing the internalized α2β1 integrin, cells were incubated 
with anti–α2 integrin antibody (A211E10) and subsequently with 
rabbit anti–mouse IgG and protein A gold and processed for EM as 
described previously (Upla et al., 2004). Briefly, cells were fixed in 
4% PFA containing 0.1% glutaraldehyde in 50 mM Tris buffer, pH 
7.6, at room temperature for 1 h or at +4°C overnight. Cells were 
then dehydrated, stained with 2% uranylacetate, and embedded in 
LX-112 Epon. For cryoimmuno–EM, cells were treated as described 
recently (Karjalainen et al., 2011). Briefly, clustered cells were fixed 
with 4% PFA-PBS for 10 min and scraped, with fixation continued up 
to 30 min, and pelleted by centrifugation. Cells were embedded in 
12% gelatin-PBS and saturated overnight in 2.3 M sucrose. After 
cryosectioning, sucrose/methyl cellulose film was dissolved with ex-
tensive PBS washes, and free aldehyde groups were blocked with 
0.1% glycine/PBS for 30 min. Sections were then blocked with 10% 
FCS/PBS for 20 min and washed twice with PBS. Sections were la-
beled for 30 min with primary antibodies rabbit calpain-2 or control 
IgG in 5% FCS/PBS and washed extensively with PBS. PA-gold 
(5 nm) was allowed to react for 20 min in 5% FCS/PBS, after which 
sections were washed with PBS and water and finally coated with 
methyl cellulose/uranyl acetate.
added on the precipitate samples for 5 and 60 min at +37°C. When 
used, calpain inhibitor calpeptin was added before calpain enzymes. 
Samples were separated by SDS–PAGE, and radioactive gels were 
treated with enhancer solution, dried, and exposed against X-ray 
film at −80°C. Band size and intensities from the film were analyzed 
with Adobe Photoshop (San Jose, CA).
Surface biotinylation, immunoprecipitation, 
and immunoblotting
Cells growing in 10% fetal bovine serum containing medium were 
placed on ice, and cell surface proteins were labeled with 0.5 mg/ml 
of EZ-Link sulfo-NHS-LC-biotin (Thermo Scientific) in Hank’s bal-
anced salt solution (Sigma-Aldrich) for 30 min at +4°C. Unbound 
biotin was washed away, and α2 integrins were clustered with 
A211E10 and rabbit anti–mouse antibodies as described. The nega-
tive control sample was incubated only with the secondary antibody. 
The biotinylated integrins were allowed to internalize at +37°C, af-
ter which cells were washed and lysed by scraping in lysis buffer 
(50 mM octyl-β-d-glucopyranoside, 1% NP-40, 0.5% BSA, 1 mM 
EDTA, with phosphatase and protease inhibitor cocktails [Roche]), 
followed by 20 min of incubation at +4°C. Cell extracts were cleared 
by centrifugation (16,000 × g, 10 min, +4°C), and the clustered inte-
grins were immunoprecipitated with protein G–Sepharose beads 
(GE Healthcare) for 1 h at +4°C. The unclustered control samples 
were incubated with monoclonal α2 antibody (A211E10) for 1 h at 
+4°C before immunoprecipitation. Samples were separated on 
7.5% SDS–PAGE gel, and the biotinylated integrins were detected 
from immunoblots with HRP-conjugated anti-biotin antibody (Cell 
Signaling Technology, Beverly, MA).
For total α2 integrin immunoprecipitation, polyclonal rabbit α2 
integrin antibody (ab1936) was used. For β1 integrin immunopre-
cipitation rat β1 integrin antibody (Mab13) or mouse β1 integrin an-
tibody (12G10) was used. Rabbit anti-rat or rabbit anti–mouse anti-
bodies were bound to PA–Sepharose to immunoprecipitate Mab13 
or 12G10, respectively. Samples were loaded and separated in 7.5% 
SDS–PAGE gel and electroblotted onto polyvinylidene fluoride 
membrane (Millipore). The blot was blocked for 1 h at room tem-
perature with 5% BSA in 0.1% Tween-Tris buffered saline (TBS). Pri-
mary and secondary antibodies in 5% BSA and in 0.1% Tween-TBS 
were incubated for 1 h sequentially. The bands were detected by 
chemiluminescence with the ChemiDoc XRS gel documentation 
system (Bio-Rad).
Recycling assays
In the bleaching experiment, SAOS-α2β1 cells were cultivated on 
Lab-Tek eight-well plates (Nalge Nunc International, Rochester, NY). 
α2β1 integrin was clustered on ice as described. The plates were 
transferred to a Zeiss confocal setup and kept at +37°C. After inte-
grin internalization for 2.5 h, edges of the cell were bleached com-
pletely with high-intensity laser excitation (40 iterations with argon 
laser were used). z-Sections through the cells were taken before and 
after bleaching and subsequently with 1-h intervals until 6.5 h.
In the recycling assay, using the quenching anti-Alexa anti-
body, EV1 was first bound on cells on ice, after which integrin 
was clustered with anti–α2 integrin antibody (MCA2025) and 
goat anti–mouse Alexa 488. After 1 h of internalization, all cells 
except nontreated samples were treated for 30 min on ice with 
0.024 mg/ml anti–Alexa 488 antibody in 1% DMEM to quench 
fluorescence of the surface remaining Alexa 488 signal. Thereaf-
ter, cells were quenched after 1 h intervals with anti–Alexa 488 
antibody on ice repetitively for 4 h. Control cells were treated 
with 1% DMEM. Samples after each quenching period were fixed 
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SAOS-α2β1 cells were fixed with 4% PFA for 20–30 min, permeabi-
lized with 0.2% Triton X-100 in PBS for 5 min, and treated with 
antibodies diluted in PBS containing 3% bovine serum albumin. 
For Rab7 labeling, cells were permeabilized with 0.05% saponin. 
Goat secondary antibodies (conjugated to Alexa dye 488, 555, or 
594) against rabbit and mouse antibodies (Invitrogen) were used. 
The cells were mounted in Mowiol–1,4-diazabicyclo[2.2.2]octane 
and examined with an Axiovert 100 M SP epifluorescence micro-
scope (Carl Zeiss) equipped with a confocal setup (Zeiss LSM510) 
or with an Olympus microscope IX81 with a FluoView-1000 confo-
cal setup.
Data analysis of the microscopic data
Quantification of fluorescence intensity and colocalization was de-
termined with BioImageXD. Levels for the laser power, detector am-
plification, and optical sections were optimized for each channel in 
the confocal microscope before starting the quantification. The co-
localization thresholds were set manually to eliminate background 
fluorescence. Statistical significance of observed colocalization was 
calculated by Costes’ algorithm (Costes et al., 2004) embedded in 
software, and only colocalization with zero coincidence probability 
was taken into account (i.e., p = 1.000).
Fluorescence intensity of cells from confocal images was evalu-
ated by intensity threshold segmentation. The intensity threshold 
was selected experimentally so that the background fluorescence 
was eliminated. Objects were defined from the background and 
connected objects separated with segmentation tools. Average in-
tensity of the object was normalized to average area of the object or 
number of vesicles to produce sum of intensities.
t-BOC intensity was defined by first smoothing images with a 
Gaussian kernel. After that, fixed experimentally defined intensity 
threshold was used for all images, and all connected regions with 
fewer than three pixels were removed to eliminate photon shot 
noise. Regions for cell area calculation were defined by first smooth-
ing images with a Gaussian kernel and thresholding using an auto-
matic Otsu method.
To analyze recycling and degradation of α2β1 integrin, three-di-
mensional confocal images of single cells or two-dimensional im-
ages of multiple cells were first smoothed using a Gaussian kernel. 
The objects were then defined by sequential procedures using dy-
namic threshold, Euclidean distance mapping, and morphological 
watershed segmentation. From the resulting regions, total fluores-
cence was normalized by the cell number.
Statistical testing
Statistical pairwise comparison of samples was done with the t 
test. For percentages or ratio figures, the t test was applied after 
arcsine square root transformation of the original variable to con-
vert the binomial distribution of the data to follow normal 
distribution.
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